Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

  • Daniel J. Fullen,
  • Nicolas Noulin,
  • Andrew Catchpole,
  • Hosnieh Fathi,
  • Edward J. Murray,
  • Alex Mann,
  • Kingsley Eze,
  • Ganesh Balaratnam,
  • Daryl W. Borley,
  • Anthony Gilbert,
  • Rob Lambkin-Williams
  • Article
  • Metrics
  • Comments
  • Media Coverage

Fig 11, “Mean mucus weight by day in all subjects in the Human Viral Challenge Model.” is a duplicate of Fig 9, “Mean symptom score by day in symptom positive subjects in the Human Challenge Viral Model.” Please view the correct Fig 11 here.

thumbnail
Fig 11. Mean mucus weight by day in all subjects in the Human Viral Challenge Model.

https://doi.org/10.1371/journal.pone.0157211.g001

Reference

  1. 1. Fullen DJ, Noulin N, Catchpole A, Fathi H, Murray EJ, Mann A, et al. (2016) Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLoS ONE 11(1): e0145902. pmid:26761707